Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 18Thoracic 1NET 1Head & Neck 1Genitourinary 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 29Lung Neoplasms 16Small Cell Lung Carcinoma 10Breast Neoplasms 8Esophageal Neoplasms 5Sarcoma 4Neoplasms 4Melanoma 4Colorectal Neoplasms 4Advanced Lung Cancer 4Stomach Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Thoracic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Mesothelioma 2Colonic Neoplasms 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Adenocarcinoma of Lung 2Widespread Small Cell Lung Cancer 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Uncommon Pathological Types of Lung Cancer 1Thyroid Neoplasms 1Testicular Neoplasms 1Squamous Cell Lung Cancer 1

Interventions

pembrolizumab 24Nivolumab 19atezolizumab 9Specimen Handling 7Magnetic Resonance Spectroscopy 7Cyclophosphamide 7durvalumab 5Ipilimumab 5fludarabine 4Trastuzumab 4cemiplimab 3cabozantinib 3avelumab 3Sunitinib 3Biopsy 3ulixertinib 2toripalimab 2tislelizumab 2spartalizumab 2sargramostim 2relatlimab 2palbociclib 2lenvatinib 2epacadostat 2enzalutamide 2cyclopropapyrroloindole 2copanlisib 2budigalimab 2aldesleukin 2X-Rays 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Injections × Thoracic × Clear all
NCT07348211 2026-01-23

SIM0610-101

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 1 Recruiting
260 enrolled
GastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡